Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.

Annals of surgical oncology - 1 Nov 2020

Murphy Brittany L, Yi Min, Arun Banu K, Gutierrez Barrera Angelica M, Bedrosian Isabelle

Abstract excerpt

BACKGROUND: An increasing number of breast cancer patients are undergoing expanded genetic testing and are being identified as germline mutation carriers. We sought to determine rates of contralateral risk-reducing mastectomy (CRRM) in patients with various germline mutations. PATIENTS AND METHODS: All women ≥ 18 years of age with unilateral breast cancer who underwent multigene panel testing between January 1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Breast Cancer Treatment Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Male Breast Health Studies

Share to Mastectomy

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 32720048
DOI: 10.1245/s10434-020-08889-6
PMCID: PMC7554051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.PMID 32720048Read ↗

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.Semantic proximity Read ↗

Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.Semantic proximity Read ↗

ASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers.Semantic proximity Read ↗

Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.Semantic proximity Read ↗

Timely Cancer Genetic Counseling and Testing for Young Women With Breast Cancer: Impact on Surgical Decision-making for Contralateral Risk-reducing MastectomySemantic proximity Read ↗

Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysisSemantic proximity Read ↗

Does bilateral mastectomy affect clinical outcomes in BRCA1/2 mutation carriers with primary breast cancer? A systematic review and meta-analysis.Semantic proximity Read ↗

Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Semantic proximity Read ↗

Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.Semantic proximity Read ↗

Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer.Semantic proximity Read ↗

Breast cancer surgery in the era of genetic uncertainty: real-world outcomes in BRCA1/2 pathogenic variants and variants of uncertain significance.Semantic proximity Read ↗

Influence of germline test results on surgical decision making in women with invasive breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.